3646 results for «519»
3646 results
Featured Research - Aortic valve (Part 5)
25 Nov 2024 – From PCR London Valves 2024
This session features a selection of research abstracts from PCR London Valves 2024, covering a wide range of topics related to aortic valve interventions. Explore insights on predicting pacemaker need after TAVI, the impact of commissural misalignment and leaflet laceration, long-term outcomes with different valve types,...
Featured cases - TAVI embolisation (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore a captivating collection of featured TAVI cases from PCR London Valves 2024. Witness the management of complex complications such as valve embolization, retrograde migration, and coronary sequestration. Discover innovative percutaneous retrieval techniques, cases of multiple valves in TAVI, and strategies for handling acute valve migration...
Featured Cases - TAVI embolisation (Part 2)
25 Nov 2024 – From PCR London Valves 2024
This session features a selection of challenging TAVI cases from PCR London Valves 2024, focusing on the management of TAVI embolization and unexpected events. Learn from real-world experiences on handling transcatheter aortic valve dislodgement, migration, and other complications, and discover innovative techniques for successful bailout strategies.
Featured cases - Paravalvular leak closure
24 Nov 2024 – From PCR London Valves 2024
Dive into a captivating session showcasing selected PCR London Valves 2024 clinical cases on paravalvular leak closure. Witness the use of a hybrid approach for aortic paravalvular leaks, the management of infective endocarditis complications, and the percutaneous treatment of complex malpositioned valves. Explore interventions to address...
Coronary sinus reducer for microvascular angina
28 Feb 2020
A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation
05 Sep 2023
The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...
Author
Author
